CTN Bulletin logo
September 18, 2023  

Get CTN Library "What's New" Blog Posts by Email!

Did you know the CTN Dissemination Library has a news blog! Until now, you had to go to the website to see what was new – but we’ve (finally!) added a subscription option that lets you sign up to receive new posts by email!

What kind of information will you receive if you subscribe?

  • Updates from Nodes and Protocols
  • News from NIDA
  • News from NIAAA, the Addiction Technology Transfer Center (ATTC) Network, NIH, and other federally funded initiatives
  • Funding and fellowship opportunities
  • New articles, presentations, and more in the CTN Library
  • Upcoming events, webinars, and training (we also have an event calendar too!)


We also welcome submissions! We’d love to get updates from you about what your node or protocol are up to, your latest CTN-related paper or presentation/poster, or upcoming events your node or protocol are involved in (let us help you market!). Send items for the blog (which will also be included in the monthly CTN Bulletin) to us at ctnlib@uw.edu!

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

JSAT Special Issue: Call for Papers on Implementation Science in Addiction TreatmentJSAT cover

The Journal of Substance Use & Addiction Treatment (JSAT) is seeking abstracts for a special issue on addiction treatment implementation research, including quantitative research, theory-driven or -generating qualitative studies, study protocols, systematic reviews, and meta-analyses.

One-page abstracts of the proposed paper are due by November 1, 2023, and must be submitted to Dr. Mark McGovern at mpmcg@stanford.edu. (Reminder that all CTN-related papers have to be approved by the Publications Subcommittee before being submitted for publication!  Please email Susan Sonne( sonnesc@musc.edu) and Jack Blaine (jblaine@nida.nih.gov) for more information.)

Find more details about the JSAT submission here.

CTN Trial Progress

GraphRandomizations for Active Studies as of the September 17 Trial Progress Report.

CTN-0080 - Enrolled 140

CTN-0096 - Enrolled 12

CTN-0098 - Enrolled 174

CTN-0099 - Enrolled 1663

Discontinuation -
Enrolled 183
Retention -
Enrolled 890

CTN-0101 - Enrolled 202

CTN-0107 - Enrolled 150

CTN-0108 - Enrolled 102

CTN-0109 - Enrolled 40

CTN-0110 - Enrolled 17

CTN-0116 - Enrolled 125

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Additions, Drug & Alcohol Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Upcoming Events

CTN snowflake logo over image of doctor holding tabletCTN Steering Committee Meeting

September 19, 2023 | 2-4pm ET

CTN members are invited to join the next CTN Steering Committee Meeting, which will be held virtually on September 19, 2023 (2-4pm PT).

The agenda will include final study reports for CTN-0134 (Buprenorphine-Precipitated Withdrawal Hotspots and Correlates) and CTN-0105 (Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders), as well as a presentation from the Office of Research Training, Diversity, and Disparities on training opportunities to leverage the CTN Network (funding mechanisms and programs).

Download agenda | Connect to the Zoom session | Full Zoom info

Xylazine event logoXylazine Discussion Forum for CTN Investigators

September 26, 2023 | 4-5:30pm ET

Join the Center for the Clinical Trials Network (CCTN) on Tuesday, September 26, 2023 from 4:00-5:30pm ET for a virtual Xylazine Discussion Forum for CTN investigators.

Speakers Jeanmarie Perrone, MD (University of Pennsylvania) and Rachel Haroz, MD (Cooper University and Rowan University) will highlight the emerging threat of xylazine in the U.S. illicit drug supply, summarize emerging practices for treating people taking xylazine-adulterated opioids, and discuss research gaps and opportunities identified in a recent meeting of experts convened by NIDA. CTN researchers will be encouraged to participate in discussion and Q&A.

Register for the Xylazine Discussion Forum here!

Sunset over GuamGuam's 4th Annual Conference on SUD Among Pacific Islanders

September 27-28, 2023 (virtual, free)

The Guam Behavioral Health and Wellness Center and Pacific Southwest Addiction Technology Transfer Center cordially invite you to register for Guam’s Fourth Annual Conference on Substance Use Disorders among Pacific Islanders.

This live virtual conference is available at no-cost and is scheduled to take place during National Recovery Month on September 27-28, 2023 from 8:00am-2:30pm ChST.

Earn CE/CME credits while attending presentations on clinical interventions, emerging issues in behavioral health care, mental health, opioids and stimulants, populations with specific service needs, prevention, and women/children/families. (full agenda here; watch for the teal marker that reads "CME available" for sessions offering continuing medical education credits).

Ken CarpenterCTN Youth SIG Webinar: Parent-to-Parent Community Support: Helping Families Come Into Contact with Evidence-Informed Concepts and Strategies in the Context of Shared Lived Experience

November 2, 2023 | 11am-12pm ET

PresenterKen M Carpenter, PhD
Research Scientist, Division on Substance Use Disorders, New York State Psychiatric Institute
Director of Training, CMC:Foundation for Change

Dr. Carpenter’s more recent community-based work has focused on developing resources that can be utilized by parent peer support networks to help bring evidence-informed concepts and skills to families impacted by substance use problems. He will present on pilot programs directed towards engaging families outside of the clinical service framework. The discussion will include lessons learned from these projects, continued efforts to grow a parent-to-parent support community, and the continued challenges that come along with supporting parent-to-parent efforts to promote evidence informed concepts and strategies in the context of community-based groups.

Connect to the Zoom session

CTN snowflake logoSave the Date: Addictions Research Meets Lived Experience: Lessons Learned, Opportunities and Challenges

Oct 30, 1-2:30pm ET

Peer support services have expanded to a wide variety of health service settings, and evaluating the impact of peer services is an important addition to the research agenda. In this webinar, the presenters and panel members will share lessons learned in conducting trials with persons with lived experience -peers-participating as an integral component of the intervention. The goal of the webinar is to assist investigators in designing future studies with peers as interventionists. The agenda includes an overview of the development of peer services in addiction treatment, a brief description of three research projects, and a panel discussion of peer supervision, self-care, scope of practice, fidelity, harm reduction approaches, and role induction for peers in research. The audience will have the opportunity to ask questions and engage in discussion with the presenters and panel members.   

Presenters: Keith Humphries, Kelly Barth, Steve Shoptaw, Nabila El-Bassel, Todd Korthuis
Panel Members: Al Hasson (facilitator), Todd Korthuis, Louise Haynes, Pete Smith, Joanna Cooper

Registration will be coming soon – watch the CTN Library What’s New blog for more information or email Sean Randol at the CCTN: srandol@leedmci.com

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Attention Early-Career Investigators: Apply for the 2024 LEAD Program!

Person typing on laptop with text APPLY NOWThe Learning for Early Careers in Addiction and Diversity (LEAD) Program provides training to early-career research scientists from racial/ethnic minoritized groups that are underrepresented in the substance use and substance use disorder research field. [download/share flyer]

The program uses the NIDA Clinical Trials Network (CTN) as a platform for training early-career investigators. This 3-year training program is based at the University of California, San Francisco (UCSF), and visiting scholars spend three summers in a 4-week intensive program at UCSF.

During the academic year, scholars work with their primary mentor to collaborate on substance use and substance use disorder treatment research conducted in the CTN, develop a professional research network, and conduct a pilot study that will serve as a preliminary study for subsequent NIH funding.

The program provides travel and housing funds for scholars, as well as pilot study funding. The 2024 summer program begins on July 8th and ends August 2nd.

Learn more about the eligibility and selection criteria and apply to the LEAD program here. The deadline is November 30, 2023.

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from the Nodes

New England Consortium Node

New England Consortium Node member: Angela Haeny, PhD, assistant professor of psychiatry and director of the Racial Equity & Addiction Lab, was the recipient of the 2023 Early Career Investigator Award from the Translational Mechanisms of Behavior Change (MOBC) Satellite Meeting at the Research Society on Alcohol (RSA).

New Publication including NEC Node members: Ren Boyu, Lipsitz Stuart R, Weiss Roger D, Fitzmaurice Garrett M. Methods for handling missing binary data in substance use disorder trials. Drug Alcohol Depend 2023 Sep 1;250:110897. doi: 10.1016/j.drugalcdep.2023.110897

New Publication including NEC Node members:Paschen-Wolff M, Greenfield SF, Kathryn McHugh R, Burlew K, Pavlicova M, Choo TH, Barbosa-Leiker C, Ruglass LM, Mennenga S, Rotrosen J, Nunes EV, Campbell ANC. Clinical and psychosocial outcomes by sex among individuals prescribed buprenorphine-naloxone (BUP-NX) or extended-release naltrexone (XR-NTX) for opioid use disorder. Am J Addict. 2023 Aug 15. doi: 10.1111/ajad.13463

New Publication including a NEC Node Participating Site (Boston Medical Center): Liu J, Pan Y, Nelson MC, Gooden LK, Metsch LR, Rodriguez AE, Tross S, Del Rio C, Mandler RN, Feaster DJ. Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV. AIDS Behav. 2023 Sep;27(9):2915-2931. doi: 10.1007/s10461-023-04015-1

WSN logoWestern States Node

Webinar recording available!

Did you miss the recent webinar cosponsored by the Western States Node and the Northwest and Pacific Southwest ATTCs? You can now access the slides and recording!

In the presentation, David Hodgins, PhD and Matthew Young, PhD described key deliverables from their Lower-Risk Gambling Guidelines project, including the lower-risk limits for expenditure, frequency and number of types of games.

They also presented a self-assessment quiz, a suite of posters and other knowledge mobilization tools that are freely available to those who with use or promote the guidelines.

Find the slides and recording here!


Northeast Node

Hybrid Event for Northern New Englanders: Addressing the Intersection of Pain Management and Opioid Use, September 29, 2023

Logo for the event

The New England Opioid Response Network and CTN Northeast Node are pleased to bring together experts in the fields of pain and opioid use at a Regional Summit to be held in Concord, New Hampshire, on Friday, September 29, 2023.

This event is intended for Northern New England audiences (Maine, New Hampshire, and Vermont).

We invite all who provide care to patients that experience pain (acute or chronic), use opioids, or have opioid use disorder, to attend. This interdisciplinary team-based training will provide evidence-based solutions to managing pain and opioid use.

In-person attendance is encouraged but limited – register now to reserve your seat! Virtual attendance is also an option but may not be as rewarding.

Interdisciplinary continuing education credits will be available (see details in registration). The content for this Summit was developed by leadership at our Node and our New England ORN team at Brown University.

For more information & to register, please visit the summit website.

News from the ATTC Network

ATTC logoSyndemic Solutions Summit: "No Wrong Door" for Access by Greg Grislano (ATTC Network Coordinating Office). ATTC Messenger, August 2023.

Prevention: A Public Health Strategy for Affecting Change by Margaret Brommelsiek, PhD. (Research brief)

NIATx in New Places: Empowering Teams in Recovery Community Organizations with NIATx by Kris Kelly and Maureen Fitzgerald. ATTC|NIATx Service Improvement blog, September 2023.

ATTC/NIATx's Top 10 Posts from Our First Decade -- This month marks a decade of partnership and collaboration between the ATTC Network and NIATx on a shared blog, the ATTC|NIATx Service Improvement blog. They've compiled a list of their 10 favorite posts from the decade. Check them out here!

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

Journal coversNew in the CTN Dissemination Library

Capturing Drug Use Patterns at a Glance: An n-ary Word Sufficient Statistic for Repeated Univariate Categorical Values. Odom GJ, et al. PLoS One 2023 (in press). CTN-0094

Prevalence of Cannabis Use Disorder and Reasons for Use Among Adults in a US State Where Recreational Cannabis Use is Legal. Lapham GT, et al. JAMA Network Open 2023;6(8):e2328934. CTN-0077-Ot

Integrative Data Analysis of Clinical Trials Network Studies to Examine the Impact of Psychosocial Treatments for Black People Who Use Cocaine: Study Protocol. Haeny AM, et al. Contemporary Clinical Trials 2023 (in press). CTN-0125

Naltrexone Plus Bupropion Reduces Cigarette Smoking in Individuals with Methamphetamine Use Disorder: A Secondary Analysis from the CTN ADAPT-2 Trial. Schmitz JM, et al. Journal of Substance Use and Addiction Treatment 2023;151:208987. NIDA-CTN-0068

Association Between Cannabis Use Disorder Symptom Severity and Probability of Clinically-Documented Diagnosis and Treatment in a Primary Care Sample. Matson TE, et al. Drug and Alcohol Dependence 2023:110946 (in press). CTN-0077-Ot

· · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · · ·

News from NIDA

NIDA logoHigher Buprenorphine Doses Associated with Improved Retention in Treatment for Opioid Use Disorder. NIDA News Release, Sept. 18, 2023. Individuals with opioid use disorder who were prescribed a lower buprenorphine dose were 20% more likely to discontinue treatment than those on a higher dose, according to a study of patients prescribed buprenorphine in Rhode Island from 2016 to 2020, as fentanyl became widely available.

The study,  published September 18th in JAMA Network Open, was supported by the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, and conducted by researchers at Brown University, Providence, Rhode Island; NIDA and the Rhode Island Department of Health.

Innovative Projects Answer NIDA's Challenge to Implement Substance Use Prevention in Primary Care. Nora's Blog, August 22, 2023.


Upcoming Events

HEAL Pain Partnering Meeting
October 4-5, 2023 (virtual)
This meeting will convene investigators, members of industry, private funders, and NIH staff to address challenges within the commercial landscape of pain therapeutics, and to create connections between HEAL-funded investigators and potential partners.

Addiction Health Services Research (AHSR) Conference
October 18-20, 2023 | New York, NY
The Addiction Health Services Research (AHSR) conference, held since 2005, brings together researchers, policymakers, and treatment providers to focus on how systems redesign can effectively and sustainably be implemented.

For more upcoming events, visit the CTN Dissemination Library's Event Calendar.



Published by the CTN Dissemination Library of the Pacific Northwest Node
Addictions, Drug & Alcohol Institute, University of Washington

This project is supported by a grant from the National Institute on Drug Abuse to the University of Washington Addictions, Drug & Alcohol Institute, but the information on this site has not been reviewed by NIDA and does not necessarily reflect the views of the Institute.

Unsubscribe | Subscribe